1. Arena’s APD418 Receives FDA’s Fast Track Designation to Treat Patients with Decompensated Heart Failure Published: Jan 17, 2020 | Tags: Arena, APD418, Receives, FDA, Fast Track Designation, Treat, Patients, Decompensated […]readmore
Tags : Genome & Company
Shots: Genome & Company enters into a clinical trial and supply agreement with Merck KGaA and Pfizer to evaluate the safety, tolerability, biological and clinical activities of GEN-001 + Bavencio […]readmore